Blocknomi
Key Takeaways Shares of Ionis Pharmaceuticals plummeted nearly 20% following disappointing results from the CARDIO-TTRansform Phase 3 clinical trial for eplontersen Collaboration partner AstraZeneca saw its stock decline approximately 9%…
Related articles
-
XRP, Shiba Inu (SHIB), Solana (SOL) and Bitcoin (BTC) Price Analysis for June 8: Momentum Is Not Fueled Yet
U.Today Published 08.07.2026 00:01
-
OpenAI Will Reportedly Stagger GPT-5.6 Release at US Government Request
BeInCrypto Published 25.06.2026 23:30
-
S&P 500 Earnings Trap: Can a 26% Profit Hurdle Survive the AI Capex Hangover?
Crypto Daily Published 04.07.2026 15:01
-
Bitcoin Falls to $62,000 as Trump’s Iran Ceasefire Comments Rattle Markets
Bitcoin.com Published 08.07.2026 12:59
-
Coinbase opens Luxembourg MiCA hub as EU deadline nears
Crypto.News Published 25.06.2026 05:48
-
Ethereum Holds Near $1,625 As Traders Look For A Rotation Trade
Bitcoinist Published 05.07.2026 19:05
-
HOOD Climbs 8% on Robinhood Chain Launch and an AI Guinness Record
BeInCrypto Published 02.07.2026 12:03
-
Here’s what happened in crypto today
Cointelegraph Published 26.06.2026 06:04